Proton pump inhibitors: Risks of long-term use

被引:134
作者
Eusebi, Leonardo Henry [1 ,2 ,3 ]
Rabitti, Stefano [1 ]
Artesiani, Maria Laura [1 ]
Gelli, Dania [1 ]
Montagnani, Marco [1 ]
Zagari, Rocco Maurizio [1 ]
Bazzoli, Franco [1 ]
机构
[1] Univ Bologna, St Orsola Univ Hosp, Dept Med & Surg Sci DIMEC, Gastroenterol & Endoscopy Unit, Bologna, Italy
[2] Royal Free Hampstead NHS Fdn Trust, HPB Dis, London, England
[3] UCL Inst Liver & Digest Hlth, London, England
关键词
complications; long-term risk; proton pump inhibitor; GASTRIC-CANCER; ANTIPLATELET THERAPY; CIRRHOTIC-PATIENTS; GUT MICROBIOME; ACID; ABSORPTION; CALCIUM; METAANALYSIS; OMEPRAZOLE; PANTOPRAZOLE;
D O I
10.1111/jgh.13737
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Proton pump inhibitors are among the most commonly prescribed classes of drugs, and their use is increasing, in particular for long-term treatment, often being over-prescribed and used for inappropriate conditions. In recent years, considerable attention has been directed towards a wide range of adverse effects, and even when a potential underlying biological mechanism is plausible, the clinical evidence of the adverse effect is often weak. Several long-term side effects have been investigated ranging from interaction with other drugs, increased risk of infection, reduced intestinal absorption of vitamins and minerals, and more recently kidney damage and dementia. The most recent literature regarding these adverse effects and their association with long-term proton pump inhibitor treatment is reviewed, and the mechanisms through which these possible complications might develop are discussed.
引用
收藏
页码:1295 / 1302
页数:8
相关论文
共 75 条
  • [21] Letter: long-term use of proton pump inhibitors and risk of neuroendocrine tumours
    Ezekwudo, D.
    Tobi, M.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 43 (06) : 749 - 749
  • [22] Food and Drug Administration, 2011, FDA DRUG SAF COMM LO
  • [23] Food and Drug Administration, 2010, FDA DRUG COMM POSS I
  • [24] Food and Drug Adminstration, 2009, FDA UPD LAB CLOP BIS
  • [25] No Association Between Gastric Fundic Gland Polyps and Gastrointestinal Neoplasia in a Study of Over 100,000 Patients
    Genta, Robert M.
    Schuler, Christopher M.
    Robiou, Cristian I.
    Lash, Richard H.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2009, 7 (08) : 849 - 854
  • [26] Association of Proton Pump Inhibitors With Risk of Dementia A Pharmacoepidemiological Claims Data Analysis
    Gomm, Willy
    von Holt, Klaus
    Thome, Friederike
    Broich, Karl
    Maier, Wolfgang
    Fink, Anne
    Doblhammer, Gabriele
    Haenisch, Britta
    [J]. JAMA NEUROLOGY, 2016, 73 (04) : 410 - 416
  • [27] CURRENT CONCEPTS IN THE DIAGNOSIS OF COBALAMIN DEFICIENCY
    GREEN, R
    KINSELLA, LJ
    [J]. NEUROLOGY, 1995, 45 (08) : 1435 - 1440
  • [28] Risk of dementia in elderly patients with the use of proton pump inhibitors
    Haenisch, Britta
    von Holt, Klaus
    Wiese, Birgitt
    Prokein, Jana
    Lange, Carolin
    Ernst, Annette
    Brettschneider, Christian
    Koenig, Hans-Helmut
    Werle, Jochen
    Weyerer, Siegfried
    Luppa, Melanie
    Riedel-Heller, Steffi G.
    Fuchs, Angela
    Pentzek, Michael
    Weeg, Dagmar
    Bickel, Horst
    Broich, Karl
    Jessen, Frank
    Maier, Wolfgang
    Scherer, Martin
    [J]. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2015, 265 (05) : 419 - 428
  • [29] Hagiwara Tadashi, 2015, Asian Pac J Cancer Prev, V16, P1315
  • [30] Proton pump inhibitors suppress absorption of dietary non-haem iron in hereditary haemochromatosis
    Hutchinson, Carol
    Geissler, Catherine A.
    Powell, Jonathan J.
    Bomford, Adrian
    [J]. GUT, 2007, 56 (09) : 1291 - 1295